Our clinical research

With a traslational-basis, our trials are grouped under three programs:

Clinical Trial Program

Phase I, II and III classical trials, proof-of-concept. Involving quite a large period of time, they give us information on a drug’s efficacy.

Biomarker Program

Trials with no drug-intervention. Samples collection + correlative analysis of tumors and liquid biopsies. Looking for clinically-predictive biomarkers and mechanisms of resistance.

Window Program

Very informative trials at a biological level. They take advantage of the period between the diagnosis and surgery to test new therapeutic strategies.